Yahoo Finance

Nemus Bioscience, Inc. Announces Letter of Intent to License Biosynthetic Technology to Manufacture Its Proprietary Cannabinoid Molecules From Teewinot Life Sciences Corp.

COSTA MESA, CA and TAMPA, FL--(Marketwired - Jun 10, 2016) - NEMUS Bioscience, Inc. (OTCQB: NMUS) announced it signed a letter of intent (LOI) with Teewinot Life Sciences Corp. that is expected to ...
Business Insider

Teewinot Life Sciences Corporation, a Global Leader in Pharmaceutical Cannabinoid Production, to Present at CBI's Biopharma Forum on Cannabis-Based Therapies

Dr. Richard Peet to discuss "Mastering Clinical Trials for Emerging Cannabis Therapies" TAMPA, Florida, Nov. 27, 2017 /PRNewswire/ -- Teewinot Life Sciences Corporation ("Teewinot"), is an ...
Business Insider

Teewinot Life Sciences Corporation, a Global Leader in Pharmaceutical Cannabinoid Production, Secures $12.3 Million Series B Round

Furthers Mission to Address Unmet Medical Needs Across the Globe NEW YORK and TAMPA, Florida, May 1, 2017 /PRNewswire/ -- Teewinot Life Sciences Corporation (Teewinot), an industry leader in discovery ...
Yahoo Finance

NetworkNewsWire Releases Exclusive Audio Interview with Teewinot Life Sciences

New York, New York--(Newsfile Corp. - February 6, 2018) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions ...
PR Newswire

Teewinot Life Sciences Secures First U.S. Patent Covering a Commercial Process for Biosynthetic Production of authentic THCA, CBDA and CBCA Cannabinoids

TAMPA, Florida, June 7, 2016 /PRNewswire/ -- Teewinot Life Sciences Corporation (Teewinot), a global leader in the use of synthetic biology to create pharmaceutical grade cannabinoids, announced today ...